Ameet Mallik's most recent trade in Adc Therapeutics SA was a trade of 675,000 Common Shares done . Disclosure was reported to the exchange on June 30, 2026.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Adc Therapeutics SA | Ameet Mallik | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Jun 2026 | 675,000 | 2,121,769 | - | 0 | Common Shares | |
| Adc Therapeutics SA | Ameet Mallik | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 3.99 per share. | 13 Feb 2026 | 900,000 | 1,550,000 | - | 4.0 | 3,591,000 | Common Shares |
| Adc Therapeutics SA | Ameet Mallik | Director, Chief Executive Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 3.99 per share. | 13 Feb 2026 | 103,231 | 1,446,769 | - | 4.0 | 411,892 | Common Shares |
| Adc Therapeutics SA | Ameet Mallik | Director, Chief Executive Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 3.29 per share. | 06 Dec 2025 | 233,146 | 1,319,101 | - | 3.3 | 767,050 | Common Shares |
| Atara Biotherapeutics Inc | Ameet Mallik | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Jun 2025 | 7,828 | 16,928 (0%) | 0% | 0 | Common Stock | |
| Adc Therapeutics SA | Ameet Mallik | Director, Chief Executive Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 1.29 per share. | 06 May 2025 | 26,758 | 1,552,247 | - | 1.3 | 34,518 | Common Shares |
| Adc Therapeutics SA | Ameet Mallik | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 1.61 per share. | 13 Feb 2025 | 650,000 | 1,579,005 | - | 1.6 | 1,046,500 | Common Shares |
| Adc Therapeutics SA | Ameet Mallik | Director, Chief Executive Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 3.13 per share. | 06 Dec 2024 | 238,343 | 929,005 | - | 3.1 | 746,014 | Common Shares |
| Adc Therapeutics SA | Ameet Mallik | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 4.48 per share. | 07 May 2024 | 29,731 | 1,167,348 | - | 4.5 | 133,195 | Common Shares |
| Atara Biotherapeutics Inc | Ameet Mallik | Director | 31 Mar 2024 | 150,000 | 227,500 (0%) | 0% | 0 | Common Stock | ||
| Atara Biotherapeutics Inc | Ameet Mallik | Director | 31 May 2023 | 79,500 | 79,500 | - | - | Non-Qualified Stock Option (Right to Buy) | ||
| Atara Biotherapeutics Inc | Ameet Mallik | Director | 31 May 2023 | 57,000 | 77,500 (0%) | 0% | 0 | Common Stock | ||
| Atara Biotherapeutics Inc | Ameet Mallik | Director | 23 Jun 2022 | 31,500 | 31,500 | - | - | Non-Qualified Stock Option (Right to Buy) | ||
| Atara Biotherapeutics Inc | Ameet Mallik | Director | 23 Jun 2022 | 20,500 | 20,500 (0%) | 0% | 0 | Common Stock | ||
| Rafael Holdings Inc (Class B) | Ameet Mallik | Director | Sale or transfer of securities back to the company at price $ 0.00 per share. | 01 Feb 2022 | 908,497 | 0 (0%) | 6% | 0 | Class B Common Stock, par value $.01 per share |